Renexxion, Dr. Falk Complete Ph2b Gastroparesis Trial
27 May 2025 //
GLOBENEWSWIRE
Dr. Falk Pharma reports positive phase 3 trial on norucholic acid
07 May 2025 //
GLOBENEWSWIRE
Dr. Falk Pharma Acquires Kynos, Focuses on Acute Pancreatitis
29 Oct 2024 //
ACCESSWIRE